Using ChAP-MS to Study Macromolecular Chromatin Composition during Transcription
使用 ChAP-MS 研究转录过程中的大分子染色质组成
基本信息
- 批准号:8489555
- 负责人:
- 金额:$ 30.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAffinity ChromatographyAnimal ModelAntisense OligonucleotidesApplications GrantsAwardBinding SitesBiological ModelsBiologyCell Culture SystemCell Culture TechniquesCell LineCellsCenters of Research ExcellenceChromatinChromatin StructureChromosomesCollaborationsDNA BindingDNA biosynthesisDefectDevelopmentDiseaseEngineeringEpigenetic ProcessEukaryotic CellFeasibility StudiesFundingFutureGene TargetingGenesGeneticGenetic EngineeringGenetic TranscriptionGenomicsGoalsGrantHistonesHumanHuman Cell LineLaboratoriesLinkMacromolecular ComplexesMalignant NeoplasmsMammalian CellMass Spectrum AnalysisMeasuresMetabolismMethodologyModelingMusNatureOrganismParticipantPatientsPositioning AttributePost-Translational Protein ProcessingProceduresProtein AnalysisProteinsProteomicsReagentRegulationResearch PersonnelSaccharomyces cerevisiaeSaccharomycetalesSamplingSister ChromatidSiteStructureTechniquesTechnologyTestingTherapeuticTissuesTranscriptional RegulationTranslatingTriciribine PhosphateUnited States National Institutes of HealthWorkYeastscombinatorialepigenomicshuman diseasehuman tissuein vivoinsightnew technologynovelprogramsprotein protein interactionpublic health relevancerecombinational repairresearch and developmentsegregationskillstechnology developmenttissue/cell culturetool
项目摘要
DESCRIPTION (provided by applicant): One of the most compositionally diverse structures in a eukaryotic cell is a chromosome. A multitude of macromolecular protein interactions must properly occur on chromatin to drive functional aspects of chromosome biology like gene transcription, DNA replication, recombination, repair, and sister chromatid segregation. Importantly, unwanted alterations in PTM states and defects in the enzymatic machineries that regulate chromatin metabolism are linked to a wide variety of illnesses and diseases that are epigenetic in scope, including cancer. However, analyzing how protein assemblies interact in vivo with chromatin to direct these activities remains a significant challenge due to the temporal and dynamic nature of their associations. The in vivo analysis of macromolecular protein interactions in the context of chromatin has been a primary collaborative focus of the Taverna and Tackett laboratories for the last 6 years. Together, using the complementary skill sets of our groups, we have developed novel tools to unambiguously identify protein- protein interactions of macromolecular complexes on chromatin. Most importantly, our combined efforts recently culminated in the development of a technique termed Chromatin Affinity Purification with Mass Spectrometry or ChAP-MS. ChAP-MS provides for the enrichment of a unique 1 kb section of a chromosome for site-specific identification of macromolecular protein interactions and associated histone posttranslational modifications. The establishment of ChAP-MS in human cells will permit unprecedented insight into mammalian transcription regulation as well as epigenetic disregulation in human disease, and potentially mechanisms of action for therapeutics. In this proposal, we hypothesize that ChAP-MS can be adapted to human cell culture and tissues to provide a novel tool for the analysis of in vivo macromolecular protein interactions. Our short-term goal is to apply ChAP-MS to human cell lines and tissues, while our long-term goal is to move development into animal models like mice and to use ChAP-MS to profile across an entire chromosome. To test our hypothesis and work towards our short term goal, we will pursue the following three Aims: (1) Develop and Apply ChAP-MS for the analysis of macromolecular chromatin composition at actively transcribing genes in mammalian cell lines, (2) Develop an antisense enrichment procedure for ChAP-MS and (3) Application of Multiplex ChAP-MS in mammalian cells and tissues.
描述(由申请人提供):真核细胞中最多样化的结构之一是染色体。必须在染色质上正确发生多种大分子蛋白质相互作用,以驱动染色体生物学的功能方面,例如基因转录,DNA复制,重组,修复和姐妹染色质分离。重要的是,调节染色质代谢的PTM状态的不良改变和酶促机制的缺陷与包括癌症在内的范围表观遗传的多种疾病和疾病有关。但是,由于其关联的时间和动态性质,分析蛋白质组件如何与染色质在体内相互作用是指导这些活动的重大挑战。在过去的6年中,在染色质中对大分子蛋白相互作用的体内分析一直是Taverna和Tackett Laboratories的主要协作重点。共同使用我们组的互补技能集,我们开发了新颖的工具,可以明确鉴定染色质上大分子分子复合物的蛋白质蛋白质相互作用。最重要的是,我们最近的合并努力最终达到了一种用质谱或章节-MS的染色质亲和力纯化的技术的开发。 Chap-MS提供了染色体的独特的1 Kb截面的富集,用于特定于位点的大分子蛋白相互作用和相关组蛋白后翻译后修饰。在人类细胞中的建立将允许对哺乳动物转录调控以及人类疾病中的表观遗传学的前所未有的见解,以及对治疗疗法的可能作用机制。在此提案中,我们假设Chap-M可以适应人类细胞培养和组织,以提供一种新颖的工具,用于分析体内大分子蛋白质相互作用。我们的短期目标是在人类细胞系和组织中应用章节,而我们的长期目标是将发育转移到小鼠等动物模型中,并使用Chap-Ms在整个染色体上进行介绍。为了检验我们的假设并朝着短期目标努力,我们将追求以下三个目的:(1)开发和应用Chap-Ms,以分析在哺乳动物细胞系中主动转录基因的大分子染色质组成,(2)在Chap-Ms和(3)在Mammamal Chapue中应用抗浓度的富集程序,并在MAMMAMAL SILLIAIN中应用Mammamalian和组织中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alan Tackett其他文献
Alan Tackett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alan Tackett', 18)}}的其他基金
Identification of Druggable Targets to Complement Melanoma Therapy
确定可补充黑色素瘤治疗的药物靶点
- 批准号:
10163815 - 财政年份:2019
- 资助金额:
$ 30.92万 - 项目类别:
Identification of Druggable Targets to Complement Melanoma Therapy
确定可补充黑色素瘤治疗的药物靶点
- 批准号:
10630160 - 财政年份:2019
- 资助金额:
$ 30.92万 - 项目类别:
Identification of Druggable Targets to Complement Melanoma Therapy
确定可补充黑色素瘤治疗的药物靶点
- 批准号:
10412077 - 财政年份:2019
- 资助金额:
$ 30.92万 - 项目类别:
Center for Translational Pediatric Research (CTPR)
转化儿科研究中心 (CTPR)
- 批准号:
10380963 - 财政年份:2017
- 资助金额:
$ 30.92万 - 项目类别:
Center for Translational Pediatric Research (CTPR): Enhancing SARS-CoV-2 Sequencing Efforts for Variants in the State of Arkansas
转化儿科研究中心 (CTPR):加强阿肯色州 SARS-CoV-2 变异体的测序工作
- 批准号:
10595406 - 财政年份:2017
- 资助金额:
$ 30.92万 - 项目类别:
相似国自然基金
基于亲和导向-邻近反应的复杂体系天然蛋白固定新方法及色谱评价
- 批准号:22374116
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于亲和色谱策略筛选和挖掘磷酸酶PP2A新型调节剂
- 批准号:22377149
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于仿生亲和色谱-质谱策略的肺结核患者血清抗体谱研究
- 批准号:82160027
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于亲和色谱靶点“钩钓”策略研究补肾活血方抗AGEs诱导神经损伤的作用机制
- 批准号:82104621
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
固定化单构象态受体亲和色谱的建立及止喘灵方平喘功效物质研究
- 批准号:82174088
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
相似海外基金
Identifying neurons for interoception using simultaneous profiling of activity- and projection- specific populations
使用活动和投射特定群体的同步分析来识别用于内感受的神经元
- 批准号:
10687590 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
通过靶向溶酶体治疗 COVID-19 的宿主防御小分子开发
- 批准号:
10735492 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Development of caspase-6 inhibitors for treatment of NASH
开发治疗 NASH 的 caspase-6 抑制剂
- 批准号:
10608905 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Sigma 2 Receptor (TMEM97): Investigating the Peripheral Role of this Novel Therapeutic Target for Pain
Sigma 2 受体 (TMEM97):研究这种新型疼痛治疗靶点的外周作用
- 批准号:
10607436 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别:
Behavioral and Molecular Consequences of Tau Pathology in Locus Coeruleus in Prodromal Alzheimer's Disease
阿尔茨海默病前驱期蓝斑 Tau 蛋白病理学的行为和分子后果
- 批准号:
10604890 - 财政年份:2023
- 资助金额:
$ 30.92万 - 项目类别: